drugset / Trial / NCT07445191

Efficacy of Triamcinolone-Lidocaine Mix in Trigger Points Injection of Masseter Muscle: Double-blinded, Randomized Controlled Trial

NCT07445191

Phase 2/3 Not yet recruiting 30 enrolled Cairo University
RandomizedParallel-groupTriple-blindTreatment

Summary

This study aims to clinically evaluate the efficacy of trigger points using active drug mix (Triamcinolone with lidocaine) on relief of myofascial pain of jaw muscle.

Timeline

Start
2026-03-01
Primary completion
2026-06-01
Completion
2026-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 0.75 ml Intramuscular
Subject Lidocaine Other / unclassified 1 ml Intramuscular
Subject Triamcinolone Other / unclassified 0.25 ml Intramuscular